B
L020
vs
DD
DD
Over the past 12 months, L020 has underperformed DD, delivering a return of +46% compared to the DD's +49% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
DD
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc
F:L020
|
0.0475
EUR
|
|||||
|
Dupont De Nemours Inc
NYSE:DD
|
46.69
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
L020, DD
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
B
|
Britannia Life Sciences Inc
Revenue
|
|||||||||||
|
Dupont De Nemours Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
L020, DD
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
B
|
Britannia Life Sciences Inc
F:L020
|
|||||||||
|
Dupont De Nemours Inc
NYSE:DD
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc | ||||
|
Dupont De Nemours Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
L020, DD
Performance By Year
L020, DD
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|